| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
LONA sits in the Biotechnology industry within the Healthcare sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 776.6K | $776.65 | - | |
| CEO | 57.9K | $311.1K | - | |
| Other | 25.2K | $135.2K | - | |
| Other | 18.4K | $98.7K | - | |
| Other | 15.9K | $85.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | Renninger Robert | Chief Financial Officer | Sale+OE | 906 | $5.37 | $4,865.22 | -5.4% | +48.1% | - | |
| Mar 4, 2026 | San Martin Javier65 | Chief Medical Officer | Sale+OE | 1,720 | $5.37 | $9,236.40 | -9.8% | +48.1% | - | |
| Mar 4, 2026 | Worthington Mark | General Counsel and CCO | Sale+OE | 1,328 | $5.37 | $7,131.36 | -6.7% | +48.1% | - | |
| Mar 4, 2026 | Litton Mark James | President and CEO | Sale+OE | 5,156 | $5.37 | $27,687.72 | -8.2% | +48.1% | - | |
| Mar 4, 2026 | Church Kevin | Chief Scientific Officer | Sale+OE | 1,359 | $5.37 | $7,297.83 | -5.1% | +48.1% | - |